Compare JILL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JILL | SENS |
|---|---|---|
| Founded | 1959 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.1M | 252.5M |
| IPO Year | 2017 | N/A |
| Metric | JILL | SENS |
|---|---|---|
| Price | $14.45 | $6.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $18.50 | ★ $25.58 |
| AVG Volume (30 Days) | 130.2K | ★ 373.2K |
| Earning Date | 12-10-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.19 | N/A |
| Revenue | ★ $600,981,000.00 | $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | $1.76 | $70.49 |
| P/E Ratio | $6.59 | ★ N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $13.32 | $5.25 |
| 52 Week High | $28.94 | $28.00 |
| Indicator | JILL | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 45.65 | 48.13 |
| Support Level | $13.91 | $6.03 |
| Resistance Level | $14.87 | $6.44 |
| Average True Range (ATR) | 0.69 | 0.35 |
| MACD | -0.05 | -0.13 |
| Stochastic Oscillator | 24.76 | 17.91 |
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.